Select Sidearea

Populate the sidearea with useful widgets. It’s simple to add images, categories, latest post, social media icon links, tag clouds, and more.

SFA Therapeutics Announces FDA Clearance for Amendment to Extend Phase 1b Trial of SFA-002 for Psoriasis


Ira Spector, CEO of SFA Therapeutics will be presenting a corporate update at the Biotech Showcase,on January 11, 2023, at 10:45 AM in the Franciscan Ballroom A, at the Hilton Hotel in Union Square in San Francisco.

Biotech Showcase™ and its family of events, China Showcase, Digital Medicine & Medtech Showcase and Seed Showcase, are investor conferences devoted to providing private and micro-mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives.  Featuring over 400 curated presenting companies from around the world, from seed-stage companies to public, multi-national companies, from platform technology to therapeutic areas to digital health and device and diagnostics, the event attract investors representing over USD 400 Billion in capital, and highly motivated strategic partners in the life science ecosystem.

Biotech Showcase will be delivered in a new hybrid format. In-person components will take place January 10–12, 2022 at the Hilton San Francisco Union Square in San Francisco, CA. Virtual event components will follow the week after, January 17–19, 2022, hosted on partneringONE®—ONE login. ONE seamless digital experience.